Indivior Pharmaceuticals Inc
INDV
株式のランク
#4004
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
株価
$32.56
最終同期: 2026-10-16
時価総額
$4.06B
変化（1日）
-3.15%
変化（1年）
33.01%
国
US
取引 Indivior Pharmaceuticals Inc (INDV)
カテゴリー
Healthcare
Indivior Pharmaceuticals Inc（INDV）のEPS
June 2026 時点のEPS TTM: $2.84
Indivior Pharmaceuticals Incの最新の財務報告と株価によると、同社の現在のEPS（TTM）は$2.84です。2023年末には、EPSは$0.01で、2022年のEPS$-0.37と増加でした。
Indivior Pharmaceuticals IncのEPS履歴（2016から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
